convulsant treatment was never started. The patient also had severe brittle asthma and died later at home in status asthmaticus. Postmortem examination was not carried out.
Effect of verapamil on enzyme release after early intravenous administration in acute myocardial infarction: double blind randomised trial Verapamil has infarct reducing properties in experimental myocardial infarction and experimental myocardial ischaemia. In dogs comparisons of different agents with these properties showed a 20% reduction in infarct size after propranolol and a 40% reduction in size after verapamil.' Decreased elevation of the ST segment has been reported in several studies. Reduction of myocardial necrosis as quantified histologically and prevention of haemodynamic deterioration have also been described.2 Nayler et al found that verapamil protected ischaemic rabbit hearts as shown by release of intracellular enzymes, depletion of adenosine triphosphate reserves, and diminishing ultrastructural cellular damage, the best results occurring after prophylactic use of the drug. 3 We have conducted a clinical trial to assess whether verapamil administered early in acute myocardial infarction reduced infarct size as estimated by the release of creatine kinase into the circulation. During the trial period 417 patients were admitted to the unit. Two hundred were excluded from the trial and the remaining 217 began treatment. Of the 119 of these patients who fulfilled the WHO criteria for acute myocardial infarction, 19 were later excluded because cumulated creatine kinase values could not be calculated. Reasons were: admission after maximal values had been attained (nine patients), insufficient blood samples (five), death during first 72 hours (two), defibrillation (one), refusal to participate (one), and administrative mistakes (one). Of the 19 patients, 13 were in the verapamil group and six in the placebo group. Cumulated creatine kinase values were therefore available for 100 patients.
The median time from onset of pain to admission was four hours (range 0-5-12-0 hours). Fifty four of the patients received verapamil, and their mean cumulated creatine kinase value was 3711 ± SEM 269 U/I. Forty six patients received placebo, and their mean cumulated creatine kinase value was 3436 ±SEM 288 U/I. The difference was not significant (t=0-70, df=98, 0 4 < p < 0 6) (figure). There was no difference between the treatment groups in age, sex, fractional disappearance rate of creatine kinase, or site of the infarct. 
Comment
Using the cumulated creatine kinase value as an indication of myocardial damage, this study failed to confirm experimental evidence of infarct reducing properties of verapamil. Dosages of the drug were equivalent to those used in the animal experiments, and the delay before treatment was of the same magnitude as that in the beta-blocker studies reporting a reduction of infarct size. In the experimental studies, however, verapamil was administered either before or shortly after the induced coronary event. Hence the four hour delay in our study might have been responsible for the negative result. Unilateral somatic symptoms due to hyperventilation
Recurrent unilateral sensory or motor symptoms (or both) are a poorly recognised presentation of the hyperventilation syndrome. We have seen 12 such cases during the past two years and here describe two cases in detail and 10 in tabular form.
Case reports
Case 1-A 19 year old school leaver unable to find work gave a six month history of recurrent episodes of numbness and weakness of her left hand and arm. Each episode lasted a few minutes and she simultaneously felt dizzy, light headed, had difficulty taking a deep breath, and felt tightness in the chest. Investigation elsewhere for suspected epilepsy proved negative. Physical examination showed no abnormality, though she was overtly anxious: voluntary hyperventilation reproduced all her symptoms. She was reassured and the mechanism explained. A physiotherapist taught her breathing exercises, which she continued for a few weeks. When reviewed two years later she was well without recurrence of symptoms.
Case 6-A 30 year old male banker had had intermittent paraesthesiae affecting the left face, arm, and leg for four months. Episodes lasted several minutes and could recur up to three times a week. He was referred with suspected cerebrovascular disease. Physical examination showed no abnormality but he was anxious about his job. Voluntary hyperventilation reproduced his attacks but no other symptoms such as dizziness. After explanation he was taught breathing exercises by a physiotherapist and remained free of symptoms when reviewed two years later.
The table summarises details of 12 cases (including the above). Individual episodes lasted from two to 20 minutes and had been present for between one month and two years. Left limbs were more commonly affected than the right. Only one patient complained of breathlessness even on direct questioning, and dizziness was not always present. Each patient had a background of anxiety. Physical examination showed no abnormality, but in each case voluntary hyperventilation evoked the presenting symptoms within a half to Clinical details of 12 patients with unilateral somatic symptoms due to hyperventilation 
Comment
Unilateral symptoms on hyperventilation were described in 1964 in healthy young subjects without concomitant asymmetry in the electroencephalogram and in patients without structural lesions in the nervous system.' This report gained little attention. Cases of intermittent unilateral motor or sensory symptoms are often diagnosed as epilepsy, transient ischaemic attacks, demyelination, or migraine. In view of the absence of other symptoms or physical signs, reproduction or symptoms by voluntary hyperventilation, improvement of symptoms after diagnosis and treatment, and the failure of other symptoms to develop during follow up, we think that we can exclude these diagnoses in our patients, though the follow up period in two cases was too short to exclude a structural lesion.
Are these transient unilateral symptoms due to a peripheral or central mechanism ? Peripheral nerve excitability could increase with alterations in ionised calcium concentrations and peripheral vasoconstriction of the vasa-nervorum with respiratory alkalosis.5 Experimentally cooling or rendering a limb ischaemic hastened the onset of local symptoms, while sympathectomy delayed or abolished the onset.3 Nevertheless, only a central mechanism could explain the dizziness, confusion, or even coma that hyperventilation can induce, presumably by reducing cerebral blood flow due to hypocapnia. The excess of left sided symptoms (eight of our 12 cases and 12 out of 14 healthy subjects') raises further difficulty. Is lateralisation due to cerebral dominance or to anatomical differences in the peripheral nerves and their nutrient vessels ?
When the simple procedure of hyperventilation reproduces the patient's symptoms no further investigation is necessary. We would, however, advise follow up for about a year after onset of symptoms and further investigation in those whose symptoms do not rapidly resolve with the treatment described.
We thank Sir Roger Bannister for permission to include a patient (case 4) he asked JNB to see.
Since preparation of this paper we have seen four further cases-all left sided.
'Tavel ME. Hyperventilation syndrome with unilateral somatic symptoms. J7AMA 1964;187:301-3. 
